Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Although the deleterious vasoconstrictive effects of cell-free, hemoglobin-based blood substitutes have been appreciated, the systemic effects of chronic hemolysis on nitric oxide bioavailability have not been considered or quantified. Central to this investigation is the understanding that nitric oxide reacts at least 1,000 times more rapidly with free hemoglobin solutions than with erythrocytes. We hypothesized that decompartmentalization of hemoglobin into plasma would divert nitric oxide from homeostatic vascular function. We demonstrate here that plasma from patients with sickle-cell disease contains cell-free ferrous hemoglobin, which stoichiometrically consumes micromolar quantities of nitric oxide and abrogates forearm blood flow responses to nitric oxide donor infusions. Therapies that inactivate plasma hemoglobin by oxidation or nitric oxide ligation restore nitric oxide bioavailability. Decompartmentalization of hemoglobin and subsequent dioxygenation of nitric oxide may explain the vascular complications shared by acute and chronic hemolytic disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Priapism, nephropathy, and sickle vasculopathy are associated with hemolysis.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“In these complications HbF has a less obvious beneficial effect, perhaps because only a small number of lysed sickle erythrocytes are needed to trigger these subphenotypes.59”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“As HbF falls and fewer F-cells are protected from HbS polymer damage, the propensity for vascular occlusion and intravascular hemolysis increases with the release of heme products into the circulation that scavenge nitric oxide causing endothelial damage and vasculopathy.[57][58][59]”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“A further consequence of sickling of cells is increased RBC hemolysis. Hemolysis affects not only the number of circulating RBCs but also release of Hb (and other cytoplasmic proteins) within the blood stream, thus profoundly affecting the viscosity and colloid properties of plasma and increasing systemic NO scavenging (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
In the citing paper
“For example, in hemolytic anemia, release of free Hb may lead to systemic NO scavenging, affecting vascular tone (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
Citations
Cites
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Mechanism of NO-induced oxidation of myoglobin and hemoglobin
Eich, R. F., Li, T., Lemon, D. D., Doherty, D. H., Curry, S. R., Aitken, J. F., Mathews, A. J., Johnson, K. A., Smith, R. D., Phillips, et al. (1996) · Biochemistry · doi:10.1021/bi960442g · Cited by 613
Diffusion-limited reaction of free nitric oxide with erythrocytes
Liu, X., Miller, M. J. S., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., & Lancaster, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18709 · Cited by 512
A Tutorial on the Diffusibility and Reactivity of Free Nitric Oxide
Lancaster, J. R. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0112 · Cited by 495
Nitric oxide in the human respiratory cycle
McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., et al. (2002) · Nature Medicine · doi:10.1038/nm718 · Cited by 469
Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441
Self-citationRate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
Doherty, D. H., Doyle, M. P., Curry, S. R., Vali, R. J., Fattor, T. J., Olson, J. S., & Lemon, D. D. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-672 · Cited by 432
Autoxidation kinetics of aqueous nitric oxide
Ford, P. C., Wink, D. A., & Stanbury, D. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81748-o · Cited by 419
Research works printed but not linked: 3
- Vaughn, M.W., Kuo, L. & Liao, J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274, H1705–H1714 (1998).
- Vogel, W.M., Dennis, R.C., Cassidy, G., Apstein, C.S. & Valeri, C.R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am. J. Physiol. 251, H413–H420 (1986).
- Pohl, U. & Lamontagne, D. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res. Cardiol. 86, 97–105 (1991).
Cited by
Items 701–800 of 1,000
Scheffer, F. R., Silveira, C. P., Morais, J., Bettini, J., & Cardoso, M. B. (2020) · Langmuir · doi:10.1021/acs.langmuir.0c01545 · Cited by 20
Qin, Z., Yang, M., Lu, Z., Babu, V. S., Li, Y., Shi, F., Zhan, F., Liu, C., Li, J., & Lin, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843662 · Cited by 26
Kołcz, J., Karnas, E., Madeja, Z., & Zuba‐Surma, E. K. (2022) · Journal of Intensive Care · doi:10.1186/s40560-022-00639-y · Cited by 21
“As a potent NO scavenger, free hemoglobin causes a rapid drop in NO bioavailability in the vascular system, leading to impaired tissue perfusion and organ dysfunction, systemic and local pro-inflammatory activation, ischemia–reperfusion damage and metabolic dysregulation [12, 13].”
BackgroundNeutrophils in sickle cell disease: Exploring their potential role as a therapeutic target
de Ligt, L. A., Gaartman, A. E., Biemond, B. J., Fijnvandraat, K., van Bruggen, R., & Nur, E. (2024) · American Journal of Hematology · doi:10.1002/ajh.27224 · Cited by 24
“50 Increased levels of cell-free heme result in increased ROS production, eliciting a pro-inflammatory, pro-adhesive state of neutrophils.”
BackgroundInfrared imaging of nitric oxide-mediated blood flow in human sickle cell disease
Gorbach, A. M., Ackerman, H. C., Liu, W., Meyer, J., Littel, P. L., Seamon, C. A., Footman, E., Chi, A., Zorca, S. M., Krajewski, M. L., et al. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.06.011 · Cited by 20
“(Eberhardt et al., 2003; Reiter et al., 2002), agents that directly stimulate vascular smooth muscle relaxation via soluble guanylate cyclase.”
Self-citationThe management of painful crisis in sickle cell disease
Wright, J., & Ahmedzai, S. H. (2010) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328339429a · Cited by 20
Sakamoto, T. M., Canalli, A. A., Traina, F., Franco‐Penteado, C. F., Gambero, S., Saad, S. T. O., Conran, N., & Costa, F. F. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.09.011 · Cited by 21
Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea
Grady, A., Hankins, J. S., Haberman, B., Schoumacher, R., & Stocks, R. M. S. (2017) · Sleep And Breathing · doi:10.1007/s11325-017-1458-9 · Cited by 21
Pulmonary hypertension in Nigerian adults with sickle cell anemia
Amadi, V. N., Balogun, M. O., Akinola, N. O., Adebayo, R. A., & Akintomide, A. O. (2017) · Vascular Health and Risk Management · doi:10.2147/vhrm.s92799 · Cited by 20
“The older age of the patients with SCA patients who had PH is probably not unconnected to the longer duration of exposure to the sequelae of chronic anemia, while the association with a lower PCV may be due to the effect of cell-free hemoglobin resulting from chronic hemolysis on nitric oxide bioavailability.(7,8) Cor…”
Differences in heme and hemopexin content in lipoproteins from patients with sickle cell disease
Vendrame, F., Olops, L., Saad, S. T. O., Costa, F. F., & Fertrin, K. Y. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.08.002 · Cited by 20
Almeida, L. E. F., Kamimura, S., Batista, C. M. D. S., Spornick, N., Nettleton, M. Y., Walek, E., Smith, M. L., Finkel, J. C., Darbari, D. S., Wakim, P., et al. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.10.011 · Cited by 21
“Free hemoglobin reacting with and scavenging NO [4; 5] together with arginase competing with NO synthases (NOS) for their substrate, arginine, limit NO production by the endothelium [1; 3].”
BackgroundComplement in Sickle Cell Disease: Are We Ready for Prime Time?
Varelas, C., Tampaki, A., Sakellari, I., Anagnostopoulos, Α., Gavriilaki, E., & Vlachaki, E. (2021) · Journal of Blood Medicine · doi:10.2147/jbm.s287301 · Cited by 21
The potential of Angeli's salt to decrease nitric oxide scavenging by plasma hemoglobin
He, X., Azarov, I., Jeffers, A. B., Presley, T. D., Richardson, J., King, S. B., Gladwin, M. T., & Kim‐Shapiro, D. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.038 · Cited by 21
Self-citationHaptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia
Sertorio, J. T. C., Lacchini, R., Amaral, L. M., Palei, A. C., Cavalli, R. D. C., Sandrim, V. C., Duarte, G. G., & Tanus-Santos, J. E. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2012.57 · Cited by 22
Self-citationPulmonary hypertension in hemolytic anemias
Wahl, S. K., & Vichinsky, E. P. (2010) · F1000 Medicine Reports · doi:10.3410/m2-10 · Cited by 20
“Cell-free hemoglobin has been shown to be a potent scavenger of NO, effectively preventing these vasoprotective properties [10].”
BackgroundGonsalves, C. S., Li, C., Malik, P., Tahara, S. M., & Kalra, V. K. (2015) · Bioscience Reports · doi:10.1042/bsr20150190 · Cited by 22
Musa, B. M., Galadanci, N. A., Coker, M. O., Bussell, S. A., & Aliyu, M. H. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2693-z · Cited by 22
Soluble CD163 levels in children with sickle cell disease
Møller, H. J., Nielsen, M. J., Bartram, J. L., Dick, M. C., Height, S. E., Moestrup, S. K., & Rees, D. C. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08580.x · Cited by 20
“…component of the pathophysiology of SCD, causing the release of free haemoglobin in to the plasma, where it binds strongly to and inactivates nitric oxide (NO) (Reiter et al, 2002); this functional NO deficiency causes endothelial dysfunction, which may contribute to progressive vascular damage.”
BackgroundMorphological and functional platelet abnormalities in Berkeley sickle cell mice
Shet, A. S., Hoffmann, T. J., Jiroušková, M., Janczak, C. A., Stevens, J. R. M., Adamson, A. S., Mohandas, N., Manci, E. A., Cynober, T., & Coller, B. S. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.01.008 · Cited by 20
A Novel Mechanism for Pulmonary Arterial Hypertension?
Cooke, J. P. (2003) · Circulation · doi:10.1161/01.cir.0000087153.11050.ab · Cited by 20
Hydroxyurea in sickle cell disease: our experience in Western India
Deshpande, S. V., Bhatwadekar, S. S., Desai, P., Bhavsar, T., Patel, A., Koranne, A., Mehta, A., & Khadse, S. (2016) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-015-0542-1 · Cited by 19
“Finally, the Hydroxyurea molecule contains a Nitrous Oxide moiety that can be released directly through unknown metabolic processes [22] Nitrous Oxide has beneficial effects on vascular endothelium, including local vasodilatation, and could help offset proposed hemolysis-related NO consumption [23].”
BackgroundHokka, M., Egi, M., Kubota, K., & Mizobuchi, S. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.04.029 · Cited by 19
Endothelin in Renal Injury due to Sickle Cell Disease
Tharaux, P. (2011) · Contributions to nephrology · doi:10.1159/000328699 · Cited by 19
Kosenko, E. A., Tikhonova, L. A., Alilova, G. A., Urios, A., & Montoliu, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010206 · Cited by 21
Recent advances in “sickle and niche” research - Tribute to Dr. Paul S Frenette -
Torres, L. S., Asada, N., Weiss, M. J., Trumpp, A., Suda, T., Scadden, D. T., & Ito, K. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.06.004 · Cited by 19
“17 j 1509–1535 j July 12, 2022 compartmentalized oxygenated hemoglobin (Fe) degrades nitric oxide (NO), a key inhibitor of vascular contractility (Doherty et al., 1998; Reiter et al., 2002).”
BackgroundSakai, H., Sato, A., Okuda, N., Takeoka, S., Maeda, N., & Tsuchida, E. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00352.2009 · Cited by 19
“Regarding in vivo blood circulation, once Hb is released from the RBCs in pathological conditions and after administration of cell-free Hb-based blood substitutes, the Hb induces various side effects (3, 18, 20).”
BackgroundPotential role for statins in sickle cell disease
Adam, S. S., & Hoppe, C. C. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24443 · Cited by 19
“HU has been shown to increase intravascular generation of NO in SCD [53,57,58], and patients treated with HU demonstrate elevated plasma NOx levels [57,59–61].”
BackgroundThe role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases
BUTROUS, G. S. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.42 · Cited by 22
Simoni, J. M., Simoni, G., Griswold, J., Moeller, J. F., Tsikouris, J. P., Khanna, A., Roongsritong, C., & Wesson, D. E. (2006) · ASAIO Journal · doi:10.1097/01.mat.0000235282.89757.9f · Cited by 19
De-Oliveira, A. C. A., Carvalho, R. S., Paixao, F., Tavares, H. S., Gueiros, L. S., Siqueira, C. M., & Paumgartten, F. J. R. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-81 · Cited by 29
“It should be pointed out that intravenous infusions of cell free haemoglobin and chronic haemolysis due to sickle-cell disease limit NO bioavailability as well [50].”
BackgroundWood, K. C., Durgin, B. G., Schmidt, H. M., Hahn, S. A., Baust, J., Bachman, T. N., Vitturi, D. A., Ghosh, S., Ofori-Acquah, S. F., Mora, A. L., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000621 · Cited by 20
Self-citationEfficacy of blood transfusion in the critically ill: Does age of blood make a difference? *
Napolitano, L. M., & Corwin, H. L. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000110676.93531.05 · Cited by 19
“Limited nitric oxide bioavailability promotes regional and systemic vasoconstriction and subsequent organ dysfunction (21, 22).”
BackgroundBuehler, P. W., Swindle, D. C., Pak, D. I., Fini, M. A., Hassell, K. L., Nuss, R., Wilkerson, R. B., D’Alessandro, A., & Irwin, D. C. (2021) · Pulmonary Circulation · doi:10.1177/20458940211055996 · Cited by 19
Host-Derived Cytotoxic Agents in Chronic Inflammation and Disease Progression
Arnhold, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033016 · Cited by 23
Exercise and training in sickle cell disease: Safety, potential benefits, and recommendations
Connes, P., Stauffer, É., Liem, R. I., & Nader, É. (2024) · American Journal of Hematology · doi:10.1002/ajh.27454 · Cited by 21
“4,5 Free hemoglobin scavenges nitric oxide (NO), 4,6 leading to a loss of vasodilatory capacity in patients, both in the microcirculation 7 and macrocirculation.”
Arkuszewski, M., Krejza, J., Chen, R., & Melhem, E. R. (2013) · The Neuroradiology Journal · doi:10.1177/197140091302600209 · Cited by 21
Zhang, R., Wang, Y., Pan, L., & Tian, H. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13039 · Cited by 18
Ueda, T., Kitagishi, H., & Kano, K. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob07044h · Cited by 18
Jaja, S. I., Ogungbemi, S. O., Kehinde, M., & Anigbogu, C. N. (2016) · Pathophysiology · doi:10.1016/j.pathophys.2016.04.004 · Cited by 20
Efectos adversos de la acumulación renal de hemoproteínas. Nuevas herramientas terapéuticas
Guerrero‐Hue, M., Rubio‐Navarro, A., Sevillano, Á., Yuste, C., Gutiérrez, E., Palomino‐Antolín, A., Román, E., Praga, M., Egido, J., & Moreno, J. A. (2017) · Nefrología · doi:10.1016/j.nefro.2017.05.009 · Cited by 24
Advances in new drug therapies for the management of sickle cell disease
Ataga, K. I., & Desai, P. C. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1471983 · Cited by 19
“resulting in a decrease in the required substrate for NO synthesis and further decreases the bioavailability of NO [16].”
BackgroundHayashi, T., Uchida, K., Takebe, G., & Takahashi, K. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.006 · Cited by 18
Guía de práctica clínica para el diagnóstico y tratamiento de la hipertensión pulmonar
Galiè, N., Hoeper, M. M., Humbert, M. J. C., Torbicki, A., Vachiéry, J., Barberà, J. A., Beghetti, M., Corris, P. A., Gaine, S., Gibbs, J. S. R., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73130-6 · Cited by 25
PERIPHERAL ARTERIAL TONOMETRY IN ASSESSING ENDOTHELIAL DYSFUNCTION IN PEDIATRIC SICKLE CELL DISEASE
Sivamurthy, K. M., Dampier, C., MacDermott, M., Meier, M., Cahill, M., & Hsu, L. L.-Y. (2009) · Pediatric Hematology and Oncology · doi:10.3109/08880010903271689 · Cited by 18
“Endothelial dysfunction has been identified in illnesses that share a central pathophysiology of intravascular hemolysis, such as malaria and SCD, in which NO scavenging by cell-free hemoglobin adds to reduction of NO bioavailability [3, 4].”
BackgroundRoche, C. J., Dantsker, D., Alayash, A. I., & Friedman, J. M. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.04.002 · Cited by 18
Connes, P. (2023) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-238122 · Cited by 19
“The decreased NO bioavailability is mainly due to the NO consumption by the free plasma hemoglobin and the utilization of L-arginine (the precursor of NO) by the arginase released by RBCs [48, 89].”
The effect of fresh versus standard blood transfusion on microvascular endothelial function
Parviz, Y., Hsia, C. C., Alemayehu, M., Wall, S., Bagur, R., Abu‐Romeh, N., Chin-Yee, I. H., & Lavi, S. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.05.021 · Cited by 17
Muenster, S., Beloiartsev, A., Yu, B., Du, E., Abidi, S. Z., Dao, M., Fabry, G., Graw, J. A., Wepler, M., Malhotra, R. K., et al. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001294 · Cited by 17
Nitric oxide loading reduces sickle red cell adhesion and vaso-occlusion in vivo
McMahon, T. J., Shan, S., Riccio, D. A., Batchvarova, M., Zhu, H., Telen, M. J., & Zennadi, R. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019031633 · Cited by 17
“Abnormalities of NO-dependent regulation of vascular tone in SCD have been proposed to arise from consumption of NO by plasma-free hemoglobin (Hb).(12) Hemolysis in SCD also releases erythrocyte arginase into the plasma, possibly lowering levels of arginine required for NO synthesis.”
BackgroundMechanistic insights into cell-free hemoglobin-induced injury during septic shock
Wang, J., Applefeld, W. N., Sun, J., Solomon, S. B., Feng, J., Couse, Z. G., Risoleo, T. F., Danner, R. L., Tejero, J., Lertora, J. J. L., et al. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00092.2021 · Cited by 17
Self-citationIn vivo reduction of cell‐free methemoglobin to oxyhemoglobin results in vasoconstriction in canines
Wang, D., Piknova, B., Solomon, S. B., Cortés‐Puch, I., Kern, S. J., Sun, J., Kanias, T., Gladwin, M. T., Helms, C. C., Kim‐Shapiro, D. B., et al. (2013) · Transfusion · doi:10.1111/trf.12162 · Cited by 19
Self-citationLipoprotein Subfraction Profile and HDL‐Associated Enzymes in Sickle Cell Disease Patients
Öztürk, O. H., Can, Y., Yönden, Z., Motor, S., Oktay, G., Kaya, H., & Aslan, M. (2013) · Lipids · doi:10.1007/s11745-013-3849-4 · Cited by 17
“Reduced NO bioavailability in SCD results from consumption of NO by plasma cell-free hemoglobin [6] and reactive oxygen species [1].”
BackgroundNitric oxide metabolism and the acute chest syndrome of sickle cell anemia
Sullivan, K., Kissoon, N. “., & Gauger, C. A. (2008) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181668ca9 · Cited by 18
“Hemoglobin liberated from erythrocytes by hemolysis may scavenge NO and in the process contribute to the formation of reactive oxygen species and promote pulmonary vasoconstriction (133).”
BackgroundAtteintes rénales au cours de la drépanocytose
Cazenave, M., Koehl, B., Nochy, D., Tharaux, P., & Audard, V. (2013) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2013.07.366 · Cited by 18
Complications pulmonaires des syndromes drépanocytaires majeurs chez l’adulte
Maître, B., Dessap, A. M., Habibi, A., Bachir, D., Parent, F., Godeau, B., & Galactéros, F. (2011) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2010.08.013 · Cited by 18
Tantawy, A. A. G., Adly, A. A. M., & Ismail, E. A. R. (2012) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3283573a42 · Cited by 17
Abd‐Elmawla, M. A., Rizk, S. M., Youssry, I., & Shaheen, A. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155070 · Cited by 17
“[49] showed that free Hb caused vascular dysfunction by disturbing NO bioavailability in chronic hemolytic diseases.”
BackgroundChang, T., Liu, K., Chang, C. S., Su, C., Chen, S., Lee, Y., & Chang, J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700442 · Cited by 18
Maio, R., Sciacqua, A., Bruni, R., Pascale, A., Carullo, G., Scarpino, P. E., Addesi, D., Spinelli, I., Leone, G. G., & Perticone, F. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06920810 · Cited by 19
“Reiter and coworkers reported an increased destruction of bioactive NO by [Hb] in sickle cell anemia (28).”
BackgroundUnraveling the hemolytic subphenotype of sickle cell disease
Gladwin, M. T. (2005) · Blood · doi:10.1182/blood-2005-08-3285 · Cited by 17
Self-citationRole of Toll‐like receptor 4 in intravascular hemolysis‐mediated injury
Vázquez‐Carballo, C., Herencia, C., Guerrero‐Hue, M., García‐Caballero, C., Rayego‐Mateos, S., Morgado‐Pascual, J. L., Opazo-Ríos, L., González‐Guerrero, C., Vallejo‐Mudarra, M., Cortegano, I., et al. (2022) · The Journal of Pathology · doi:10.1002/path.5995 · Cited by 17
“Hemoprotein-induced AKI involves a combination of pathogenic mechanisms, including oxidative stress, cell death, inflammation, and vasoconstriction [8,9].”
BackgroundNeuroimaging and Cognitive Function in Sickle Cell Disease: A Systematic Review
Abdi, S. S., de Haan, M. D. H., & Kirkham, F. J. (2023) · Children · doi:10.3390/children10030532 · Cited by 16
“However, aberrant cerebral haemodynamics and anaemia may make it challenging to detect fMRI activation in patients with SCD [39,40], even if the brain activity itself is undisturbed by the disease.”
BackgroundSilva, M., & Faustino, P. (2023) · Antioxidants · doi:10.3390/antiox12111977 · Cited by 22
“Consequently, in SCD, Hb autoxidation is more pronounced than in normal physiological conditions, promoting a marked pro-oxidant vascular environment, especially in the microcirculation [16].”
Pereira, D. A., Calmasini, F. B., Costa, F. F., Burnett, A. L. “., & Silva, F. H. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001962 · Cited by 16
“This process leads to the rupture of red blood cells within blood vessels, releasing hemoglobin, arginase, and other cellular contents into the circulation (Reiter et al. , 2002; Morris et al. , 2005).”
BackgroundInfluentialQuantitative analysis of heme and hemoglobin for the detection of intravascular hemolysis
Hopp, M.-T., Vaidya, S. M., Grimmig, K. M., Strudthoff, L. J., Clauser, J. C., Yuan, X., Singh, S., Müller, J., Oldenburg, J., Hamza, I., et al. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342766 · Cited by 16
Pichert, A., & Arnhold, J. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.09.009 · Cited by 16
Angeli's salt counteracts the vasoactive effects of elevated plasma hemoglobin
Solomon, S. B., Bellavia, L., Sweeney, D. J., Piknova, B., Perlegas, A. S., Helms, C. C., Ferreyra, G. A., King, S. B., Raat, N. J. H., Kern, S. J., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.548 · Cited by 18
Self-citationOwusu-Ansah, A. T., Choi, S. H., Petrošiūtė, A., Letterio, J. J., & Huang, A. Y.-C. (2014) · Frontiers of Medicine · doi:10.1007/s11684-015-0375-1 · Cited by 16
Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia
Castilhos, L. G., de Oliveira, J. S., Adefegha, S. A., Magni, L. P., Doleski, P. H., Abdalla, F. H., de Andrade, C. M., & Leal, D. B. R. (2017) · Redox Report · doi:10.1080/13510002.2017.1288973 · Cited by 19
“These complications have cyclic nature which involve the generation of excessive ROS and promotion of oxidative stress [34].”
BackgroundGrau, M., Nader, É., Jerke, M., Schenk, A., Renoux, C., Dietz, T., Collins, B., Bizjak, D. A., Joly, P., Bloch, W., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122155 · Cited by 17
Gorvitovskaia, A. Y., Scrimgeour, L. A., Potz, B. A., Sellke, N. C., Ehsan, A., Sodha, N. R., & Sellke, F. W. (2020) · Surgery · doi:10.1016/j.surg.2020.02.001 · Cited by 16
Miguel, L. I., Leonardo, F. C., Torres, L. S., Garcia, F., Mendonça, R., Ferreira, W. A., Gotardo, É. M. F., Fabris, F. C. Z., de Brito, P. L., Costa, F. F., et al. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04210-5 · Cited by 18
Targeting fetal hemoglobin expression to treat β hemoglobinopathies
Steinberg, M. H. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2066519 · Cited by 19
“NO levels enough to cause sickle vasculopathy [104].”
BackgroundQuimby, K. R., Hambleton, I. R., & Landis, R. C. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.06.023 · Cited by 17
Oguanobi, N. I., Ejim, E., Anisiuba, B. C., Onwubere, B., Ike, S. O., Ibegbulam, O. G., & Agwu, O. (2012) · ISRN Hematology · doi:10.5402/2012/768718 · Cited by 17
A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia
Hanson, M. S., Xu, H., Flewelen, T. C., Holzhauer, S., Retherford, D. M., Jones, D. W., Frei, A. C., Pritchard, K. A., Hillery, C. A., Hogg, N., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00500.2012 · Cited by 16
Self-citationL-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS)
Kanzelmeyer, N. K., Pape, L., Chobanyan-Jürgens, K., Tsikas, D., Hartmann, H., Fuchs, A.-J., Vaske, B., Das, A. M., Haubitz, M., Jordan, J., et al. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/203512 · Cited by 16
Vrancken, K., Schroeder, H. J., Longo, L. D., Power, G. G., & Blood, A. B. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00266.2013 · Cited by 16
Kang, B., Park, K., Kleinhenz, J., Murphy, T. C., Sutliff, R. L., Archer, D. R., & Hart, C. M. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0166oc · Cited by 19
Pietropaoli, A. P., Henrichs, K. F., Cholette, J. M., Spinelli, S. L., Phipps, R. P., Refaai, M. A., & Blumberg, N. (2019) · Transfusion · doi:10.1111/trf.15218 · Cited by 16
Majumdar, S., Webb, S., Norcross, E. W., Mannam, V. K. R., Ahmad, N., Lirette, S. T., & Iyer, R. V. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24473 · Cited by 17
“Sickling of red blood cells from deoxygenation [16], endothelial activation (supported by increased expression of certain adhesion molecules such as VCAM-1, ICAM-1) [17] and hemolysis associated vasoconstriction secondary to nitric oxide (NO) depletion have been shown to play an important role in the pathogenesis of v…”
BackgroundOrhan, K., Delilbaşı, Ç., & PAKSOY, C. S. (2009) · Dentomaxillofacial Radiology · doi:10.1259/dmfr/61024383 · Cited by 16
Storti, F. (2008) · Cited by 16
cGMP modulates hemin-mediated platelet death
Rohlfing, A., Kremser, M., Schaale, D., Dicenta, V., Laspa, Z., Fu, X., Zizmare, L., Sigle, M., Harm, T., Münzer, P., et al. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.12.008 · Cited by 15
Dmytriw, A. A., Martinez, J. T., Marotta, T. R., Montanera, W. J., Cusimano, M. D., & Bharatha, A. (2015) · Interventional Neuroradiology · doi:10.1177/1591019915617323 · Cited by 16
Impact of cell-free hemoglobin on contracting skeletal muscle microvascular oxygen pressure dynamics
Ferguson, S. K., Harral, J. W., Pak, D. I., Redinius, K. M., Stenmark, K. R., Schaer, D. J., Buehler, P. W., & Irwin, D. C. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.03.005 · Cited by 15
Ferreira, W. A., Chweih, H., Lanaro, C., Almeida, C. B., de Brito, P. L., Gotardo, É. M. F., Torres, L. S., Miguel, L. I., Franco‐Penteado, C. F., Leonardo, F. C., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.264606 · Cited by 16
Gbotosho, O. T., Gollamudi, J., & Hyacinth, H. I. (2023) · Biomolecules · doi:10.3390/biom13020381 · Cited by 20
“The release of free heme and cell-free hemoglobin also results in activation of neutrophils and generation of neutrophil extracellular traps (NETs) [30], iron-based generation of reactive oxidative species (ROS) with subsequent oxidization of membrane lipids [31], depletion of nitric oxide [32], and endothelial cytosk…”
BackgroundThe Novel Hemoglobin-based Oxygen Carrier HRC 101 Improves Survival in Murine Sickle Cell Disease
Crawford, M. W., Shichor, T., Engelhardt, T., Adamson, G., Bell, D., Carmichael, F. J., & Kim, P. C. W. (2007) · Anesthesiology · doi:10.1097/01.anes.0000271872.14311.b4 · Cited by 15
Nitric oxide metabolites and arginase I levels in β-thalassemic patients: an Egyptian study
El-Hady, S. M., Farahat, M., Atfy, M., & Elhady, M. A. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1427-0 · Cited by 15
Ikuta, T., Adekile, A. D., Gutsaeva, D. R., Parkerson, J. B., Yerigenahally, S. D., Clair, B., Kutlar, A., Odo, N., & Head, C. A. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.08.005 · Cited by 17
Taverne, Y. J. H. J., de Wijs-Meijler, D. P. M., Hekkert, M. T. L., Moon-Massat, P. F., Dubé, G. P., Duncker, D. J., & Merkus, D. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00677.2016 · Cited by 17
“The pressor effect of HBOC-201 has been ascribed to scavenging of NO, an important endogenous vascular relaxing factor (5, 6, 18, 44, 45, 60).”
BackgroundMorris, C. R., Vichinsky, E. P., & Singer, S. T. (2007) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-6.1.31 · Cited by 16
Free heme regulates placenta growth factor through NRF2-antioxidant response signaling
Kapetanaki, M. G., Gbotosho, O. T., Sharma, D., Weidert, F. L., Ofori-Acquah, S. F., & Kato, G. J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.08.009 · Cited by 15
Survey sheds new light on marriage and sexuality in the Philippines.
Xenos, P. S. (1997) · PubMed · Cited by 15
Saudi guidelines on diagnosis and treatment of pulmonary arterial hypertension
Idrees, M. M., Al-Hajjaj, M. S., Khan, J., Hazmi, M. A., Alanezi, M. O., Saleemi, S., Sanai, F. M., Kashour, T. S., Wali, S., & Barst, R. J. (2008) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.39589 · Cited by 14
Kunz, J. B., & Tagliaferri, L. (2024) · Transfusion Medicine and Hemotherapy · doi:10.1159/000540149 · Cited by 16
“At the same time, free hemoglobin in the plasma very effectively scavenges NO, antagonizes its vasodilatory effect, and activates endothelial cells and thrombocytes to express adhesion molecules [37].”
Adenosine receptor crossroads in sickle cell disease
Gladwin, M. T. (2011) · Nature Medicine · doi:10.1038/nm0111-38 · Cited by 15
Self-citationGladwin, M. T., Gordeuk, V. R., Desai, P. C., Minniti, C. P., Novelli, E. M., Morris, C. R., Ataga, K. I., Castro, L. D., Curtis, S. A., Rassi, F. A. E., et al. (2024) · The Lancet Haematology · doi:10.1016/s2352-3026(24)00045-0 · Cited by 15
Self-citationDefective nitric oxide metabolism in sickle cell disease
Kato, G. J. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25297 · Cited by 15
“In particular, Gladwin’s group developed a well-supported model that nitric oxide is consumed by plasma cell-free hemoglobin released during intravascular hemolysis [4].”
Background
Metadata
- Authors
- Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T.
- Affiliations
- National Institutes of Health (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Gladwin, Mark T.
- Venue
- Nature Medicine
- Published
- 2002-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 1383-1389
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4241694836
- Semantic Scholar
- 80bbf9611dbe14c7276b2a4dbca6e42007866746
- Cited by
- 1,330
- References
- 45
- Citations by year
- 2026: 44 · 2025: 39 · 2024: 45 · 2023: 39 · 2022: 57 · 2021: 55 · 2020: 56 · 2019: 59 · 2018: 60 · 2017: 45 · 2016: 62 · 2015: 63 · 2014: 69 · 2013: 68 · 2012: 68
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM55792)
- National Center for Research Resources (P41RR001008, RR 01008)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- free hemoglobin, nitric oxide bioavailability, sickle cell disease, chronic hemolysis, plasma hemoglobin, forearm blood flow, hemoglobin oxidation, vasoconstriction
- MeSH terms
- Adult, Anemia, Sickle Cell, Biological Availability, Heme, Hemocyanins, Hemoglobins, Hemolysis, Humans, Middle Aged, Nitric Oxide, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.